Pneumoconiosis Treatment and Prevention

Pneumoconiosis treatment and prevention are of significant concern for many individuals, especially those whose occupation puts them at a particularly high risk for contracting some form of this lung disease. Pneumoconiosis is a general term that can be collectively applied to lung diseases that result from inhaling particles of mineral dust, including black lung disease (caused by inhaling coal mine dust), siderosis (caused by inhaling iron dust) and silicosis (caused by inhaling silica dust). Individuals who have a high risk of developing pneumoconiosis include miners, construction workers and manufacturers, among many others.

Because pneumoconiosis gradually develops over the course of several years, early prevention and detection are key to avoiding treatment later in life. If your job requires you to be around coal mine dust, iron dust, silica dust or any other mineral dust, you should take the following steps to minimize your chances of developing pneumoconiosis:

  • Ensure proper ventilation — If you have any concerns about how your workplace is ventilated, you should voice them to your supervisor as soon as possible.
  • Wear proper attire — At the very least, be sure to wear a face mask while at work. Also make sure that your protective garments fit properly.
  • Wash your skin — Make sure to thoroughly wash any part of your body that comes into contact with mineral dust. Be particularly careful to wash your face and hands before eating or drinking. You should also remove dust from your work attire.
  • Quit smoking — Although smoking itself does not cause pneumoconiosis, it does increase your risk of developing the condition, so you should stop smoking as soon as possible.
  • Attend regular checkups — Because early detection may help to minimize any resulting damage, you should attend regular physicals and undergo routine chest X-rays. Once you’ve acquainted yourself with the common symptoms of pneumoconiosis, be sure to monitor yourself and report any concerns to your doctor as soon as possible.

If you’ve already contracted some form of pneumoconiosis, the Lung Institute offers treatment through our innovative cellular therapy procedures. Unlike some other treatment options that only address the symptoms of pneumoconiosis, cellular therapy may also slow the disease’s progression.

If you’ve developed pneumoconiosis in spite of the attempted prevention techniques and traditional treatment has not provided adequate symptom relief, please call the Lung Institute today at 888-745-6697 to discuss the benefits of our innovative cellular therapy options.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.